Anavex Life Sciences Corp. (AVXL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 759.08M |
| Enterprise Value | 656.5M |
| P/E Ratio | -10.02 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.13 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.71 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.2 |
| Return On Equity | -0.21 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -46.38M |
| Net Income | -46.38M |
| Diluted EPS | -0.54 |
| Total Cash | 118.33M |
| Total Cash/Share | 1.29 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 15.62 |
| Book Value Per Share | 1.23 |
| 52-Week Change | -72.04 |
| 52-Week High | 10.38 |
| 52-Week Low | 2.26 |
| Moving Average 50 Days | 2.87 |
| Moving Average 200 Days | 3.48 |
| Average Volume | 1.08M |
| Shares Outstanding | 92.67M |
| % Held by Institutions | 41.22 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | October 07, 2015 |